Showing results (1511-1520 of 2,131) with videos related to

Sort By:
Pageof 214
NPJ Breast Cancer|August 7, 2021
Collagen fiber orientation disorder from H&E images is prognostic for early stage breast cancer: clinical trial validationHaojia Li, Kaustav Bera, Paula Toro, et al.
The Annals of Thoracic Surgery|May 1, 1995
Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortalityD J Goldstein, J A Seldomridge, J M Chen, et al.
Current Medical Research and Opinion|April 9, 2015
Long-term efficacy of sitagliptin as either monotherapy or add-on therapy to metformin: improvement in glycemic control over 2 years in patients with type 2 diabetesH L Katzeff, D Williams-Herman, L Xu, et al.
Journal of the American College of Cardiology|August 23, 2023
Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist DeviceAditi Nayak, Shelley A Hall, Nir Uriel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 25, 2025
Early experience in heart transplantation utilizing donors with HIVOmar Saeed, Vagish Hemmige, Lorenzo D' Angelo, et al.
The Annals of Thoracic Surgery|September 1, 1996
Outpatient left ventricular assist device support: a destination rather than a bridgeK A Catanese, D J Goldstein, D L Williams, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 9, 2007
Randomized trial of tacrolimus monotherapy: tacrolimus in combination, tacrolimus alone compared (the TICTAC trial)David A Baran, Mark J Zucker, Luis H Arroyo, et al.
Clinical Transplantation|August 22, 2024
Increasing Multiorgan Heart Transplantations From Donation After Circulatory Death Donors in the United StatesShivank Madan, Jill Teitelbaum, Omar Saeed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
A phase I and pharmacokinetic study of lapatinib in combination with letrozole in patients with advanced cancerQuincy S C Chu, Mary E Cianfrocca, Lori J Goldstein, et al.
Breast Cancer Research : BCR|January 12, 2020
A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancerLori J Goldstein, Raymond P Perez, Denise Yardley, et al.
Pageof 214